Cargando…

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anshul, Dwivedi, Ankur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010852/
https://www.ncbi.nlm.nih.gov/pubmed/36923982
http://dx.doi.org/10.1055/s-0042-1757281
_version_ 1784906264088674304
author Sharma, Anshul
Dwivedi, Ankur
author_facet Sharma, Anshul
Dwivedi, Ankur
author_sort Sharma, Anshul
collection PubMed
description A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in the bone scan and the young age of the patient, he was a candidate for metastases-directed treatment. Single photon emission computed tomography (SPECT)/CT was performed to further characterize this lesion. It was revealed to be a small soft tissue density lesion within the fatty bone marrow density, suggesting bone marrow involvement. A more sensitive evaluation of such areas with faint radiotracer uptake may be needed in high-risk prostate cancer patients where access to advanced modalities is limited. Their significance will also need reassessment as their detection will improve with technological advancements.
format Online
Article
Text
id pubmed-10010852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100108522023-03-14 Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? Sharma, Anshul Dwivedi, Ankur World J Nucl Med A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in the bone scan and the young age of the patient, he was a candidate for metastases-directed treatment. Single photon emission computed tomography (SPECT)/CT was performed to further characterize this lesion. It was revealed to be a small soft tissue density lesion within the fatty bone marrow density, suggesting bone marrow involvement. A more sensitive evaluation of such areas with faint radiotracer uptake may be needed in high-risk prostate cancer patients where access to advanced modalities is limited. Their significance will also need reassessment as their detection will improve with technological advancements. Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-10-28 /pmc/articles/PMC10010852/ /pubmed/36923982 http://dx.doi.org/10.1055/s-0042-1757281 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Sharma, Anshul
Dwivedi, Ankur
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title_full Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title_fullStr Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title_full_unstemmed Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title_short Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
title_sort is further evaluation of areas with faint mdp uptake needed in individuals with oligo-metastatic prostatic adenocarcinoma?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010852/
https://www.ncbi.nlm.nih.gov/pubmed/36923982
http://dx.doi.org/10.1055/s-0042-1757281
work_keys_str_mv AT sharmaanshul isfurtherevaluationofareaswithfaintmdpuptakeneededinindividualswitholigometastaticprostaticadenocarcinoma
AT dwivediankur isfurtherevaluationofareaswithfaintmdpuptakeneededinindividualswitholigometastaticprostaticadenocarcinoma